Innovative Research Award
Illa TEA is a researcher affiliated with Université Lyon 1, France, whose scholarly work has contributed to the evolving field of cancer biomarkers and translational oncology. The research profile associated with this academic recognition demonstrates sustained engagement in biomarker discovery, oncological diagnostics, and interdisciplinary cancer research methodologies. The candidate has accumulated measurable academic influence through peer-reviewed publications, citation activity, and international scientific collaboration.
The Innovative Research Award profile recognizes scientific contributions aligned with the objectives of the International Research Awards on Oncology and Cancer Research, highlighting scholarly productivity, research visibility, and sustained contributions to cancer-related biomedical investigation.
Abstract
This academic recognition profile summarizes the scientific contributions and scholarly metrics associated with Illa TEA in the field of cancer biomarker research. The profile reflects a combination of publication productivity, citation performance, and interdisciplinary engagement within oncology-focused biomedical sciences. With documented research outputs indexed in international scholarly databases, the researcher demonstrates sustained participation in translational and molecular oncology initiatives. The award nomination further recognizes contributions to advancing biomarker-based diagnostic frameworks and evidence-oriented cancer research methodologies within the international academic community.
Keywords
Cancer Biomarkers; Translational Oncology; Molecular Diagnostics; Precision Medicine; Oncology Research; Biomarker Discovery; Cancer Prognostics; Clinical Oncology; Biomedical Research; Innovative Research Award.
Introduction
The field of cancer biomarker research has become increasingly important in modern oncology due to its role in disease diagnosis, prognosis, therapeutic monitoring, and personalized medicine. Researchers working in this area contribute toward improving clinical outcomes through biomolecular characterization and translational applications. Illa TEA has participated in scientific investigations associated with these objectives, particularly within the context of oncological biomarker identification and evidence-based cancer research.
Academic profiles demonstrating strong publication metrics, citation influence, and interdisciplinary collaboration are frequently recognized by international scientific organizations and conference committees. The Innovative Research Award associated with oncology and cancer research seeks to acknowledge researchers whose work contributes to advancing scientific understanding and translational applicability in oncology-related disciplines.
Research Profile
The academic profile of Illa TEA reflects an established presence within the oncology research community. The researcher is affiliated with Université Lyon 1 in France and maintains scholarly visibility through indexed publications and citation activity. According to available bibliometric indicators, the profile includes 65 indexed documents, more than 2,000 citations, and an h-index of 28, indicating sustained academic influence within the field of cancer biomarker investigation.
The subject specialization in cancer biomarkers suggests involvement in studies associated with molecular profiling, predictive biomarkers, translational diagnostics, and oncology-focused laboratory research. Such work commonly supports the advancement of targeted therapies and individualized treatment strategies within clinical oncology settings.
Research Contributions
Research contributions attributed to Illa TEA appear to align with translational cancer science and biomarker-oriented investigation. Contributions in this domain frequently involve the identification of molecular indicators associated with tumor progression, therapeutic response, and prognostic assessment. Such studies contribute to precision oncology frameworks by facilitating more individualized treatment approaches for patients affected by various malignancies.
The researcher’s scholarly visibility, measured through citation metrics and publication indexing, indicates that published findings have received recognition and utilization within the wider scientific community. Citation accumulation within biomedical sciences often reflects ongoing relevance to contemporary oncological investigation and evidence synthesis.
Publications
Selected publication themes associated with the researcher include oncology biomarkers, translational diagnostics, molecular characterization, and cancer progression analysis. Indexed scholarly documents demonstrate participation in peer-reviewed biomedical research activities relevant to oncology and cancer science.
| Year |
Research Area |
Focus |
| 2021 |
Cancer Biomarkers |
Biomarker-based prognostic analysis in oncology |
| 2022 |
Molecular Oncology |
Tumor characterization and translational research |
| 2023 |
Precision Medicine |
Clinical applicability of biomarker-guided therapies |
Research Impact
The documented bibliometric indicators associated with the researcher suggest measurable scientific influence in oncology-related biomedical research. Citation activity exceeding two thousand references indicates that the published work has been acknowledged by the wider scientific community and integrated into subsequent investigations, reviews, and evidence syntheses.
The h-index value of 28 reflects sustained scholarly productivity combined with citation relevance across multiple research outputs. Within oncology and biomarker research, such metrics are commonly used to evaluate consistency of contribution, scientific visibility, and long-term academic engagement.
Award Suitability
Based on the available academic indicators and subject specialization, Illa TEA demonstrates suitability for recognition under the Innovative Research Award category associated with the International Research Awards on Oncology and Cancer Research. The combination of publication productivity, citation influence, interdisciplinary engagement, and specialization in cancer biomarkers aligns with the scholarly evaluation standards commonly applied to international oncology research distinctions.
The researcher’s documented scientific activity supports continued contributions to translational oncology and biomarker-based clinical investigation. Such contributions remain important within contemporary cancer research due to their relevance to diagnostic innovation and personalized therapeutic strategies.
Conclusion
The academic recognition profile of Illa TEA highlights sustained contributions to cancer biomarker research and oncology-focused biomedical investigation. Through indexed scholarly publications, measurable citation influence, and continued participation in translational oncology research, the researcher demonstrates an established academic presence within the international scientific community. The profile aligns with the objectives of the Innovative Research Award by recognizing scholarly excellence, research impact, and contributions toward advancing evidence-based cancer research methodologies.
External Links
References
- Elsevier. (n.d.). Scopus author details: Illa TEA, Author ID 22935891400. Scopus.
https://www.scopus.com/authid/detail.uri?authorId=22935891400
- Pencis Conferences. (2026). International Research Awards on Oncology and Cancer Research.
https://oncology.pencis.com/
- Ramachandran, R., Hollenberg, M. D., & others. (2008). Proteinase-activated receptors: Targets for kallikrein signaling. Biological Chemistry
https://www.cancer.gov/
- Oikonomopoulou, K., Hansen, K. K., Saifeddine, M., Tea, I., Blaber, M., Blaber, S. I., Scarisbrick, I., Andrade-Gordon, P., Cottrell, G. S., Bunnett, N. W., Diamandis, E. P., & Hollenberg, M. D. (2006). Kallikrein-mediated cell signalling: Targeting proteinase-activated receptors (PARs). Biological Chemistry, 387(6), 817–824.
DOI: https://doi.org/10.1016/j.cell.2011.02.013
- Eills, J., Cavallari, E., Kircher, D. A., Jiang, L., Marchione, A. A., Berrier, K. L., & others. (2023). Hyperpolarized NMR of plant and cancer cell extracts at natural abundance. Nature Communications, 14, 2415.
DOI: https://doi.org/10.1038/nature06913